 |
|
|
| |
Safety Profile of HIV-1 Attachment Inhibitor Prodrug
BMS-663068 in Antiretroviral-Experienced Subjects:
Week 24 Analysis
|
| |
| |
Reported by Jules Levin
HIV Glasgow 2014,
2-6 November 2014, Glasgow, UK
J Lalezari1, GH Latiff2, C Brinson3, J Echevarría4, S Treviño-Pérez5, JR Bogner6, D Stock7, SR Joshi7, GJ Hanna8, M Lataillade7, for the AI438011 study team
1Quest Clinical Research, San Francisco, CA, USA; 2Maxwell Clinic, Durban, South Africa; 3Central Texas Clinical Research, Austin, TX, USA;
4Hospital Nacional Cayetano Heredia, Lima, Peru; 5Mexico Centre for Clinical Research, Mexico City, Mexico; 6Hospital of the University of Munich, Munich, Germany;
7Bristol-Myers Squibb, Wallingford, CT, USA; 8Bristol-Myers Squibb, Princeton, NJ, USA
|
| |
|
|
|
|
|
